FDA approves Teva’s once-monthly schizophrenia treatment
Israeli pharmaceutical giant Teva receives FDA approval for WELTRUZA, a new long-acting injection for schizophrenia that eliminates the need for daily medication.
Israeli pharmaceutical giant Teva receives FDA approval for WELTRUZA, a new long-acting injection for schizophrenia that eliminates the need for daily medication.

Findings may improve diagnostic ability and open doors to new treatments.

Researchers discover mechanism shared by mutations in different genes associated with autism, schizophrenia, and other conditions.

Likud Deputy Minister says diplomatic process is moving toward a dangerous interim accord.

A new study has found that Autism Spectrum Disorders (ASD) are linked organically to schizophrenia and bipolar disorder (manic depression).

A Palestinian Authority Arab has been sentenced to a 13-year prison term for attempting to murder a Jewish woman.
